Statins possess anti-inflammatory effects that may contribute to their ability to slow atherogenesis, whereas nitric oxide (NO) also influences inflammatory cell adhesion. This study aimed to determine whether a novel NO-donating pravastatin derivative, NCX 6550 [(1S-[1␣(S*,␦S*),2␣,6␣,8-(R*),8a␣]]-1,2,6,7,8,8a-hexahydro-,␦,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthalene-heptanoic acid 4-(nitrooxy)butyl ester)], has greater antiinflammatory properties compared with pravastatin in normal and atherosclerotic apolipoprotein E receptor knockout (ApoEϪ/Ϫ) mice. C57BL/6 and ApoEϪ/Ϫ mice were administered pravastatin (40 mg/kg), NCX 6550 (48.5 mg/kg), or vehicle orally for 5 days. Ex vivo studies assessed splenocyte adhesion to arterial segments and splenocyte reactive oxygen species (ROS) generation. NCX 6550 significantly reduced splenocyte adhesion to artery segments in both C57BL/6 (8.8 Ϯ 1.9% versus 16.6 Ϯ 6.7% adhesion; P Ͻ 0.05) and ApoEϪ/Ϫ mice (9.3 Ϯ 2.9% versus 23.4 Ϯ 4.6% adhesion; P Ͻ 0.05) concomitant with an inhibition of endothelial intercellular adhesion molecule-1 expression. NCX 6550 also significantly reduced phorbol 12-myristate 13-acetate-induced ROS production that was enhanced in isolated ApoEϪ/Ϫ splenocytes. Conversely, pravastatin had no significant effects on adhesion in normal or ApoEϪ/Ϫ mice but reduced the enhanced ROS production from ApoEϪ/Ϫ splenocytes. In separate groups of ApoEϪ/Ϫ mice, NCX 6550 significantly enhanced endotheliumdependent relaxation to carbachol in aortic segments precontracted with phenylephrine (ϪlogEC 50 , 6.37 Ϯ 0.37) compared with both vehicle-treated (ϪlogEC 50 , 5.81 Ϯ 0.15; P Ͻ 0.001) and pravastatin-treated (ϪlogEC 50 , 5.57 Ϯ 0.45; P Ͻ 0.05) mice. NCX 6550 also significantly reduced plasma monocyte chemoattractant protein-1 levels (648.8 pg/ml) compared with both vehicle (1191.1 pg/ml; P Ͻ 0.001) and pravastatin (847 Ϯ 71.0 pg/ml; P Ͻ 0.05) treatment. These data show that NCX 6550 exerts superior anti-inflammatory actions compared with pravastatin, possibly through NO-related mechanisms.Atherosclerosis is now generally acknowledged to be an inflammatory disease where inflammation develops at certain predilection sites in response to endothelial injury. Attachment of leukocytes to atherosclerotic blood vessels (Ramos et al., 1999), coupled with up-regulation of the vascular adhesion molecules vascular cell adhesion molecule-1 and ICAM-1 (Nakashima et al., 1998), is a fundamental step in the development of atherosclerosis. Recently, adhesion of cultured murine monocytoid WEH1 78/24 cells to artery segments of ApoEϪ/Ϫ mice has been demonstrated (Li et al., 2005), supporting the notion that a hyperinflammatory state exists in developing atherosclerosis. This has been attributed to increased levels of a number of cytokines, which act to elevate adhesion molecule expression. Thrombin, in addition to playing a role in the coagulation cascade, is also involved Article, publication date, and citation information can be found at